Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

Background and Aims: Angiotensin-converting enzyme II (ACE2) is the key molecule for understanding the pathophysiology of COVID-19. The risk of COVID-19 and impact of immunosuppressive treatment on disease course in patients with inflammatory bowel disease (IBD) remain controversial. We aimed to det...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiao-Zhi, Qiu, Yun, Jeffery, Louisa, Liu, Fen, Feng, Rui, He, Jin-Shen, Tan, Jin-Yu, Ye, Zi-Yin, Lin, Si-Nan, Ghosh, Subrata, Iacucci, Marietta, Chen, Min-Hu, Mao, Ren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835139/
https://www.ncbi.nlm.nih.gov/pubmed/33511147
http://dx.doi.org/10.3389/fmed.2020.613475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7835139/
https://www.ncbi.nlm.nih.gov/pubmed/33511147
http://dx.doi.org/10.3389/fmed.2020.613475

Ejemplares similares